BPC 157 significantly improved healing outcomes in both sites of treatment: macroscopically, microscopically and functionally, in addition to improving enzymatic activity (a decrease in muscle proteolysis) (Farges et al
7y Foot and Ankle Regenerative Medicine Course-Level 2 Chris Centeno, M.D
This schedule uses the largest practical dilution (3.0 mL) to maintain perinjection accuracy
Required items: Retatrutide lyophilized vial (your chosen size) Bacteriostatic water (0.9% benzyl alcohol preserved) Sterile insulin syringe for adding water (1mL or 3mL depending on volume needed) Separate sterile insulin syringe for drawing doses (do not reuse the mixing syringe) Alcohol swabs Clean, flat work surface Permanent marker for labeling A quick note on water type: you must use bacteriostatic water, not sterile water for injection, for any vial you plan to use more than once
At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story